Reference range of prostate-specific antigen after transurethral resection of the prostate

By Aus G.   Bergdahl S.   Frosing R.   Lodding P.   Pileblad E.   Hugosson J.  

Urology, Vol. 47, Iss. 4, 1996-04 ,pp. : 529-531

Elsevier

Access to resources Recommend Favorite

Nadir prostate-specific antigen as a predictor of progression to androgen-independent prostate cancer

By Benaim E.A.   Pace C.M.   Lam P.M.   Roehrborn C.G.  

Urology, Vol. 59, Iss. 1, 2002-01 ,pp. : 73-78

Elsevier

Access to resources Recommend Favorite

Disappearance of well-differentiated carcinoma of the prostate: effect of transurethral resection of the prostate, prostate-specific antigen, and prostate biopsy 1

By Endrizzi J.   Optenberg S.   Byers R.   Thompson I.M.  

Urology, Vol. 57, Iss. 4, 2001-04 ,pp. : 733-736

Elsevier

Access to resources Recommend Favorite

Methodological and clinical comparison of the ACS prostate-specific antigen assay and the tandem-E prostate-specific antigen assay in prostate cancer

By Schambeck C.M.   Schmeller N.   Stieber P.   Jansen H.-M.   Pahl H.   Schneider W.   Fateh-Moghadam A.  

Urology, Vol. 46, Iss. 2, 1995-08 ,pp. : 195-199

Elsevier

Access to resources Recommend Favorite

Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinoma

By Froschermaier S.E.   Pilarsky C.P.   Wirth M.P.  

Urology, Vol. 47, Iss. 4, 1996-04 ,pp. : 525-528

Elsevier

Access to resources Recommend Favorite